Fundz

Fundz Deep Dive

Everything you need to win CellFE — in one platform.

Who to reach, what to say, and why now on CellFE — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on CellFE — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

CellFE Launches T-Rest ('Resting T Cell Kit') to Enhance CAR-T Cell Therapy Manufacturing

Jan 22, 2025•over 1 year ago
AlamedaManufacturingBiotechnologyHealth CareTherapeutics

Product Description

CellFE has introduced T-Rest, a novel transfection media product specifically designed for resting T cell workflows in CAR-T cell therapy. This product aims to optimize gene editing workflows, promoting safer and more effective therapies by utilizing resting T cells.

Company Information

Company

CellFE

Location

Alameda, California, United States

About

CellFE is an innovative microfluidics company, whose mission is to transform the development and manufacturing of lifesaving cell therapies to make them more accessible to patients. The company uses a microfluidic-based cell engineering platform with highest cell health and payload delivery, streamlined scalability and automated workflows. Platform benefits include increased cell yield and reduced expansion times that translate to drastically reduced vein-to-vein times and manufacturing costs currently associated with advanced cell therapies. CellFE is committed to enabling their partners' success through close collaborations that aim to solve the challenges associated with the development and manufacturing of next generation cell therapies. https://www.cellfebiotech.com/

Predictive Intelligence
Strategic

ML-powered predictions for CellFE's next move

Learn about Strategic plan

Product Launch Insights

Based on market data
Market expansion signals
New product launches often coincide with market expansion initiatives

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.